Skip to main content
. 2020 Feb 21;5(2):60–66. doi: 10.7150/jbji.42448

Table 4.

Categorised distribution of outcomes after 12 months of treatment according to the antimicrobial used.

Outcome Treatment group Total
(N = 65)
P value
Colistin
(N = 34)
Tigecycline
(N = 31)
Unfavourablea 14 (41.2) 11 (35.5) 25 (38.5) 0.535b
Favourable 15 (44.1) 12 (38.7) 27 (41.5)
Lost to follow up 5 (14.7) 8 (25.8) 13 (20)

Data expressed as n (%)

aDefined as relapse, amputation or death

bChi-squared test